Pathogenesis and progression of monoclonal gammopathy of undetermined significance

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Leukemia

• Publication date

  2008-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/leu.2008.203PMID 18668131
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cytogenetics of multiple myeloma.

  2010cited by this paper
• Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma

  2010cited by this paper
• Frequency of pathological proteins (M-components) om 6,995 sera from an adult population.

  2009cited by this paper
• A 20-year follow-up study of 64 subjects with M-components.

  2009cited by this paper
• Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders.

  2008cited by this paper
• CD117 (c-kit) is aberrantly expressed in a subset of MGUS and multiple myeloma with unexpectedly good prognosis.

  2008cited by this paper
• Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression

  2007cited by this paper
• Prevalence of monoclonal gammopathy of undetermined significance: study of 52,802 persons in Nagasaki City, Japan.

  2007cited by this paper
• Hyperdiploidy Is a Common Finding in Monoclonal Gammopathy of Undetermined Significance and Monosomy 13 Is Restricted to These Hyperdiploid Patients

  2007cited by this paper
• POEMS syndrome.

  2007cited by this paper
• Monoclonal Gammopathy of Undetermined Significance: Estimated Incidence and Duration Prior to Recognition.

  2007cited by this paper
• Monoclonal gammopathy of undetermined significance: predictors of malignant transformation and recognition of an evolving type characterized by a progressive increase in M protein size.

  2007cited by this paper
• Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

  2007cited by this paper
• New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells.

  2007cited by this paper
• Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana.

  2007cited by this paper
• Monoclonal gammopathy of undetermined significance: genetic vs environmental etiologies.

  2007cited by this paper
• Hydroxyurea Use in Sickle Cell Disease Patients in a Florida Medicaid Population.

  2007cited by this paper
• Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

  2007cited by this paper
• Genetic events in the pathogenesis of multiple myeloma.

  2007cited by this paper
• Clinical practice. Monoclonal gammopathy of undetermined significance.

  2006cited by this paper
• Respiratory tract infections in the pathway to multiple myeloma: a population-based study in Scandinavia.

  2006cited by this paper
• Monoclonal gammopathy of undetermined significance

  2006cited by this paper
• Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis.

  2006cited by this paper
• Prevalence of monoclonal gammopathy of undetermined significance.

  2006cited by this paper
• Monoclonal gammopathy of undetermined significance.

  2006cited by this paper
• Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: A population‐based case‐control study

  2006cited by this paper
• Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States.

  2005cited by this paper
• Comparative genomic hybridisation identifies two variants of smoldering multiple myeloma

  2005cited by this paper
• Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance.

  2005cited by this paper
• Familial occurrence of hematologic malignancies and other diseases in multiple myeloma: a case-control study

  2004cited by this paper
• Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later.

  2004cited by this paper
• On the "significance" of monoclonal gammopathy of undetermined significance.

  2004cited by this paper
• Scleromyxedema revisited

  2003cited by this paper
• Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

  2003cited by this paper
• Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis.

  2003cited by this paper
• Smoldering multiple myeloma: natural history and recognition of an evolving type

  2003cited by this paper
• Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease.

  2003cited by this paper
• Interleukin 6 and tumour necrosis factor alpha serum levels in monoclonal gammopathy of undetermined significance

  2002cited by this paper
• Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

  2002cited by this paper
• Monoclonal gammopathy of undetermined significance.

  2002cited by this paper
• Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.

  2002cited by this paper
• A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

  2002cited by this paper
• Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells.

  2002cited by this paper
• Lymphomatous superficial lymph nodes: limitations of physical examination for accurate staging and response assessment

  2001cited by this paper
• The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications.

  2001cited by this paper
• The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance.

  2001cited by this paper
• Multiple myeloma following an episode of community acquired pneumococcal bacteraemia or meningitis

  2001cited by this paper
• The role of tumor necrosis factor α in the pathophysiology of human multiple myeloma: therapeutic applications

  2001cited by this paper
• Comparison of interleukin-1 beta expression by in situ hybridization in monoclonal gammopathy of undetermined significance and multiple myeloma.

  1999cited by this paper
• Multiple myeloma and family history of cancer among blacks and whites in the U.S.

  1999cited by this paper
• Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process

  1998cited by this paper
• Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.

  1998cited by this paper
• Cytogenetics in multiple myeloma: a multicenter study of 24 patients with t(11;14)(q13;q32) or its variant.

  1998cited by this paper
• The natural history of monoclonal gammopathy of undetermined significance. A 5- to 20-year follow-up of 263 cases.

  1997cited by this paper
• Therapeutic strategies for inhibition of interleukin-6 mediated multiple myeloma cell growth.

  1996cited by this paper
• Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy.

  1996cited by this paper
• Bone marrow angiogenesis and progression in multiple myeloma

  1994cited by this paper
• Familiality of cancer in Utah.

  1994cited by this paper
• "Benign" monoclonal gammopathy--after 20 to 35 years of follow-up.

  1993cited by this paper
• Occurrence of monoclonal components in general practice: Clinical implications

  1992cited by this paper
• Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance

  1992cited by this paper
• [The POEMS syndrome].

  1989cited by this paper
• Laboratory investigation of monoclonal gammopathy during 10 years of screening in a general hospital.

  1987cited by this paper
• Multiple myeloma and family history of cancer a case—control study

  1985cited by this paper
• 'Benign' monoclonal gammopathy. A misnomer?

  1984cited by this paper
• Monoclonal gammopathies in the adult population of Finistère, France.

  1982cited by this paper
• Monoclonal gammopathy of undetermined significance. Natural history in 241 cases.

  1978cited by this paper
• Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma.

  1972cited by this paper
• Studies on conditions associated with disturbed gamma globulin formation (gammopathies).

  1960cited by this paper

• Role of NK Cells in Progression and Treatment of Multiple Myeloma.

  2025cites this paper
• Gene Expression Analysis of the Bone Marrow Microenvironment Reveals Distinct Immunotypes in Smoldering Multiple Myeloma Associated to Progression to Symptomatic Disease

  2021cites this paper
• A nationwide study of patients with monoclonal gammopathy of undetermined significance with a 10-year follow-up in South Korea

  2021cites this paper
• STAT3 is over-activated within CD163pos bone marrow macrophages in both Multiple Myeloma and the benign pre-condition MGUS

  2021cites this paper
• Clinical and Immunological Aspects of Pneumococcal Vaccination in Patients with Multiple Myeloma

  2021cites this paper
• Role and Modulation of NK Cells in Multiple Myeloma

  2021cites this paper
• Клинические и иммунологические аспекты пневмококковой вакцинации у пациентов с множественной миеломой

  2021cites this paper
• A Case Series of MGUS and COVID19

  2020cites this paper
• Biclonal gammopathay in a case of severe COVID-19

  2020cites this paper
• A case series of Monoclonal Gammopathy of Undetermined Significance and COVID‐19

  2020cites this paper
• Re The source of elevated plasma D‐dimer levels in COVID‐19 infection

  2020cites this paper
• Gamma gap thresholds and HIV, hepatitis C, and monoclonal gammopathy

  2020cites this paper
• Immunogenicity And Safety Of The 13-Valent Pneumococcal Conjugate Vaccine In Patients With Monoclonal Gammopathy Of Undetermined Significance – Relationship With Selected Immune And Clinical Parameters

  2019cites this paper
• Three cases of monoclonal gammopathy of renal significance after kidney transplantation. De novo C3 glomerulopathy

  2019cites this paper
• CIA_A_220423 1741..1749

  2019cites this paper
• Socioeconomic Position is Positively Associated with Monoclonal Gammopathy of Undetermined Significance in a Population-based Cohort Study

  2019cites this paper
• Three cases of monoclonal gammopathy of renal significance after kidney transplantation. De novo C3 glomerulopathy.

  2019cites this paper
• Current opinions in nephrology and hypertension: kidney transplantation in patients with plasma cell dyscrasias.

  2019cites this paper
• Improving knowledge on the activation of bone marrow fibroblasts in MGUS and MM disease through the automatic extraction of genes via a nonnegative matrix factorization approach on gene expression profiles

  2018cites this paper
• Monoclonal gammopathies of unknown significance and smoldering myeloma: Assessment and management of the elderly patients.

  2018cites this paper
• MALDI-TOF analysis of blood serum proteome can predict the presence of monoclonal gammopathy of undetermined significance

  2018cites this paper
• Laboratory testing for monoclonal gammopathies: Focus on monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

  2018cites this paper
• Differential diagnosis of monoclonal gammopathies from the point of clinical practiceII. Monoclonal gammopathy of undetermined significance and other monoclonal gammopathies of the "non-malignant" origin

  2018cites this paper
• Multiple myeloma.

  2018cites this paper
• Translating the anti-myeloma activity of Natural Killer cells into clinical application.

  2018cites this paper
• Next-generation therapy for follicular lymphoma.

  2018cites this paper
• M-protein-related disorders: MGCS.

  2018cites this paper
• Abnormal Plasma Cell Disorders in Refinery Waste Workers

  2018cites this paper
• Synoptic reporting for protein electrophoresis and immunofixation.

  2018cites this paper
• Monoclonal gammopathies of renal significance.

  2017cites this paper
• Management of Patients With Hepatitis C Virus, Monoclonal Gammopathy of Undetermined Significance, and Multiple Myeloma

  2017cites this paper
• Plasma cell neoplasia after kidney transplantation: French cohort series and review of the literature

  2017cites this paper
• Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management

  2017cites this paper
• Typing of Four Cases of Monoclonal Gammopathy: A Revival of Immunosubstraction Role

  2017cites this paper
• Monoclonal gammopathies of renal significance.

  2017cites this paper
• A first Czech analysis of 1887 cases with monoclonal gammopathy of undetermined significance

  2017cites this paper
• The biological function of Cancer-testis antigen MAGE-C2/CT10 in Multiple Myeloma

  2016cites this paper
• Characterization of Monoclonal Gammopathy of Undetermined Significance by Calorimetric Analysis of Blood Serum Proteome

  2015cites this paper
• Characterization of monoclonal gammopathy in patients with amyotrophic lateral sclerosis

  2015cites this paper
• Kidney transplantation in patients with history of malignancy: Time to rethink the guidelines?

  2015cites this paper
• CME Information: Systemic mastocytosis in adults: 2015 update on diagnosis, risk-stratification, and management

  2015cites this paper
• Multiple myeloma after kidney transplantation

  2015cites this paper
• Monoclonal paraprotein influences baseline B-cell repertoire diversity and perturbates influenza vaccination-induced B-cell response.

  2015cites this paper
• A case series of autoimmune diseases accompanied by incidentally diagnosed monoclonal gammopathy: Is there a link between the two diseases?

  2014cites this paper
• Five-Year Follow-up Study of Monoclonal Gammopathy of Undetermined Significance in a Korean Elderly Urban Cohort

  2014cites this paper
• Involved/uninvolved immunoglobulin ratio identifies monoclonal gammopathy of undetermined significance patients at high risk of progression to multiple myeloma

  2014cites this paper
• Original research-Orijinal araştırma

  2014cites this paper
• Hampered influenza-specific IgG B cell responses whereas IgM and IgA responses are maintained in monoclonal gammopathy of undetermined significance

  2014cites this paper
• Profiling Bortezomib Resistance in Multiple Myeloma: Implications in Personalized Pharmacotherapy

  2014cites this paper
• Increased serum free light chains precede the presentation of immunoglobulin light chain amyloidosis.

  2014cites this paper
• Marcadores pronósticos en pacientes con gammapatía monoclonal de significado incierto

  2014cites this paper
• Influenza vaccination-induced B cell response in monoclonal gammopathy of undetermined significance (MGUS)

  2014cites this paper
• Immune Defects in the Risk of Infection and Response to Vaccination in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

  2014cites this paper
• Evidences of Early Senescence in Multiple Myeloma Bone Marrow Mesenchymal Stromal Cells

  2013cites this paper
• The utility of the BIOMED-2 primers in the detection of 2 clonal, B-lymphoproliferative disorders simultaneously involving the same site.

  2013cites this paper
• CME Information

  2013cites this paper
• Low Zip 4 gene expression levels in RPMI - 8226 and ARH - 77 cell lines support the possible role of zip 4 transporter protein in plasma cell tumorogenesis

  2013cites this paper
• Acute myeloid leukemia: 2013 update on risk‐stratification and management

  2013cites this paper
• consistently precedes multiple myeloma: a prospective study Monoclonal gammopathy of undetermined significance (MGUS)

  2013cites this paper
• Biclonal Gammopathy in a Patient taking Efalizumab for the Treatment of Psoriasis

  2013cites this paper
• Can whole-body low-dose multidetector CT exclude the presence of myeloma bone disease in patients with monoclonal gammopathy of undetermined significance (MGUS)?

  2012cites this paper
• Relapsed/Refractory multiple myeloma: defining refractory disease and identifying strategies to overcome resistance.

  2012cites this paper
• Incidental finding of monoclonal gammopathy in blood donors: a follow-up study.

  2012cites this paper
• Estudio retrospectivo de pacientes con Gammapatía Monoclonal de Significado Incierto en el área de salud 6 de Valencia

  2012cites this paper
• Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites

  2012cites this paper
• Obesity and Multiple Myeloma

  2012cites this paper
• Waldenström Macroglobulinemia: 2012 update on diagnosis, risk stratification, and management

  2012cites this paper
• Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany

  2012cites this paper
• Estado procoagulante, inflamación e inmunidad en mieloma múltiple

  2012cites this paper
• Remisión completa en el mieloma múltiple: Impacto pronóstico de las bandas oligoclonales, cociente de cadenas ligeras libres en suero y células plasmáticas residuales en médula ósea

  2011influential citation
• Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced CT.

  2011cites this paper
• Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma.

  2011cites this paper
• ) a asymptomatického mnohopočetného myelómu ( SMM )

  2011cites this paper
• Uniform examination of stem cell donors

  2011cites this paper
• Tumor Stem Cells: Therapeutic Implications of a Paradigm Shift in Multiple Myeloma

  2011cites this paper
• Uniform examination of stem cell donors

  2011cites this paper
• Monoclonal gammopathy of undetermined significance: a contraindication for living kidney donation?

  2011cites this paper
• Etanercept therapy in a hepatitis B virus (HBV)‐positive psoriatic patient developing a monoclonal gammopathy of undetermined significance

  2011cites this paper
• Atopic dermatitis-like pre-Sézary syndrome: role of immunosuppression.

  2011cites this paper
• Pathogenesis of myeloma.

  2011cites this paper
• Advances in understanding monoclonal gammopathy of undetermined significance as a precursor of multiple myeloma

  2010cites this paper
• Correlation of cytomorphology, immunophenotyping, and interphase fluorescence in situ hybridization in 381 patients with monoclonal gammopathy of undetermined significance and 301 patients with plasma cell myeloma.

  2010cites this paper
• symposium article Multiple myeloma

  2010cites this paper
• Monoclonal gammopathy of undetermined significance and smoldering myeloma: new insights into pathophysiology and epidemiology.

  2010cites this paper
• LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis.

  2010cites this paper
• Altered mRNA Expression of Telomere-Associated Genes in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

  2010cites this paper
• Changing Pattern of Presentation in Monoclonal Gammopathy of Undetermined Significance: A Single-Center Experience With 1400 Patients

  2010cites this paper
• Prevalence of monoclonal gammopathy of undetermined significance: a systematic review.

  2010cites this paper
• Vitritis and retinal vasculitis as presenting signs of monoclonal gammopathy of unknown significance with progression to multiple myeloma.

  2010influential citation
• Aggressive Systemic Mastocytosis Associated with Mesangioproliferative Glomerulonephritis

  2010cites this paper
• The role of the bone marrow microenvironment in the establishment and progression of multiple myeloma

  2010cites this paper
• Are all myelomas preceded by MGUS?

  2009cites this paper
• The incidental monoclonal protein: current approach to management of monoclonal gammopathy of undetermined significance (MGUS).

  2009cites this paper
• Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.

  2009cites this paper
• Pulmonary crystal‐storing histiocytosis diagnosed by computed tomography‐guided fine‐needle aspiration

  2009cites this paper
• Quantitation of serum free light chains does not compensate for serum immunofixation only when screening for monoclonal gammopathies

  2009cites this paper
• Monoclonal gammopathy of undetermined significance (MGUS) precedes multiple myeloma: a prospective study

  2009cites this paper
• Changes in activatory and inhibitory natural killer (NK) receptors may induce progression to multiple myeloma: implications for tumor evasion of T and NK cells.

  2009cites this paper
• Be fruitful, multiply, and replenish.

  2009cites this paper
• Crystal-Storing Histiocytosis and Crystalline Keratopathy Caused by Monoclonal Gammopathy of Undetermined Significance

  2009cites this paper